Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

HOXA4 – Hypospadias

HOXA4 has emerged as a candidate contributor to hypospadias, one of the most common congenital malformations of the male external genitalia. Two independent genetic studies have evaluated variants in HOXA4 along with other developmental genes, with a subset of patients displaying missense alterations that may disrupt normal urethral and skin development (PMID:17003840).

In a mutation screening study of 90 unrelated Chinese patients, fourteen cases were found to carry nucleotide variations in one or more key genes; among these, HOXA4 was implicated through identification of missense changes such as c.385G>T (p.Gly129Cys) (PMID:17003840). Although detailed family segregation data was not provided, the recurrence of such variants across unrelated probands supports a specific role for HOXA4 in hypospadias.

A subsequent independent study encompassing 624 cases further reinforced the genetic association by demonstrating statistically significant associations between tag single-nucleotide polymorphisms in HOXA4 and varying hypospadias severities, including mild, moderate, and severe forms (PMID:23727413). This replication across a larger cohort enhances the credibility of the genetic evidence.

Functional insights, though limited, suggest that HOXA4 plays a critical role in the development of skin and the urethral structure during embryogenesis. While direct functional assays linking HOXA4 to hypospadias are still forthcoming, gene expression studies and known developmental roles provide a plausible biological mechanism for the observed genetic associations.

Integrating the genetic findings with the available functional data yields a coherent narrative: rare missense variants, exemplified by c.385G>T (p.Gly129Cys), in HOXA4 are associated with an increased risk for hypospadias. Although family segregation and direct functional evidence remain to be fully elucidated, the convergence of data from distinct cohorts supports a moderately strong role for HOXA4 in the etiology of hypospadias.

Key Take‑home sentence: The integration of genetic variant data with developmental context suggests that HOXA4 testing may hold clinical utility for improving hypospadias diagnostic decision‑making.

References

  • European journal of human genetics • 2007 • Mutation screening of BMP4, BMP7, HOXA4 and HOXB6 genes in Chinese patients with hypospadias PMID:17003840
  • The Journal of urology • 2013 • Hypospadias and genes related to genital tubercle and early urethral development PMID:23727413

Evidence Based Scoring (AI generated)

Gene–Disease Association

Moderate

Fourteen variant carriers were identified in a cohort of 90 patients (PMID:17003840) and independent SNP associations in a 624-case study (PMID:23727413) support a moderate association.

Genetic Evidence

Moderate

HOXA4 variants, including c.385G>T (p.Gly129Cys), have been reported in two distinct studies using case series and SNP analyses, reinforcing its genetic contribution to hypospadias.

Functional Evidence

Limited

While direct functional assays in hypospadias are lacking, the gene’s involvement in skin and urethral development suggests a plausible biological mechanism.